Luca Issy's questions to Arrowhead Pharmaceuticals Inc (ARWR) leadership • Q3 2025
Question
Luca Issy's representative inquired about the initial presentation of plozasiran, asking if it will be a prefilled syringe and what the timeline is for developing an auto-injector.
Answer
SVP Andy Davis confirmed the initial launch for FCS will use a prefilled syringe. Interim Chief Medical Scientist Bruce Given added that an auto-injector is being developed for the SHTG indication and is expected to be available at or soon after that launch.